Employees Volunteer Over 1,500 Hours During Natera’s Annual Volunteer Month

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its employees contributed more than 1,500 volunteer hours during the company’s fourth annual Volunteer Month. This initiative takes place each October and is organized by Natera Nurtures, the company’s employee resource group dedicated to community service and philanthropy.

Natera encourages employees to live one of its core values, Be Ready to Change the World, by giving back to their local communities. This year, teams hosted several volunteer events supporting nonprofit organizations across the U.S.

• In Austin, Texas, volunteers sorted more than 5,600 pounds of food, equivalent to 4,725 meals, for families in need.
• In the Bay Area, employees served 120 guests in a single evening at the local Ronald McDonald House.
• In San Carlos and Pleasanton, California, more than 50 volunteers came together to make fleece blankets for children in hospitals, providing warmth and comfort to patients and their families.
• Other activities included donating blood to help over 100 patients, assembling care kits for families in need, volunteering at local animal shelters, organizing community cleanups and many more.

“Our teams make an impact both in the laboratory and in the communities we serve,” said Solomon Moshkevich, president of clinical diagnostics at Natera and executive sponsor of Natera Nurtures. “We push ourselves every day to improve upon the status quo, with better technology and better care of our patients and their families. Community service is an important way that we deliver on that commitment.”

Since 2021, Natera employees have volunteered more than 28,500 hours through company- and employee-led initiatives, significantly exceeding the organization’s five-year goal of reaching 20,000 hours by the end of 2025.

About Natera

Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit www.natera.com.

Forward-Looking Statements

All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera’s plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera’s expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy, and performance of our tests, or of the benefits of our tests and product offerings to patients, providers, and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera’s recent filings on Forms 10-K and 10-Q, and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.